Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Beta-1b and Clofazimine for COVID-19
NCT04465695Phase 2Unknown
- Sponsor
- The University of Hong Kong
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1b, clofazimine in coronavirus disease 2019 (COVID-19), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
interferon beta-1bclofazimine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04465695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04465695.